Suppr超能文献

重复给药后大鼠胃内碳酸氢根对NG-硝基-L-精氨酸甲酯分泌反应的变化

Changes in gastric HCO-3 secretory response to NG-nitro-L-arginine methyl ester in rats following repeated administration.

作者信息

Takeuchi K, Takehara K, Kato S, Asada Y, Yasuhiro T

机构信息

Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Japan.

出版信息

J Gastroenterol Hepatol. 1996 Dec;11(12):1164-70. doi: 10.1111/j.1440-1746.1996.tb01846.x.

Abstract

The effect of repeated administration of the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) on gastric HCO-3 secretion was examined using ex vivo chambered stomachs of anaesthetized rats. Intravenous administration of L-NAME (5 mg/kg) increased gastric HCO-3 secretion with a concomitant rise in arterial blood pressure (BP). The HCO-3 stimulatory action of L-NAME diminished when rats were pretreated with L-NAME (20 mg/kg, p.o., twice daily) for 1 or 3 days and an inverse relationship was found between the degree of secretory stimulation and the period of pretreatment. The increased BP response to L-NAME was also significantly lessened following repeated pretreatment; basal BP showed a stepwise increase during repeated pretreatment and did not change at all in response to i.v. L-NAME after 3 days pretreatment. When delta HCO-3 output induced by i.v. L-NAME was plotted against delta BP (from basal values) during repeated pretreatment with L-NAME, a significant relationship was found between these two factors. The reduction in the HCO3 secretory response to L-NAME was restored when animals were pretreated with L-arginine (500 mg/kg, i.p., twice daily) together with L-NAME. However, prostaglandin E2 (300 micrograms/kg, i.v.) caused a gastric HCO-3 secretory response similar to L-NAME, regardless of whether rats had been pretreated with L-NAME or not. In contrast, the attenuation by L-NAME of the acid (0.2 nmol/L HCl)-induced gastric hyperaemic response was not influenced by repeated pretreatment with L-NAME. We conclude that repeated p.o. pretreatment with L-NAME reduces the HCO-3 stimulatory action of i.v. L-NAME and that this phenomenon may be explained by the lack of further elevation of BP in response to i.v. L-NAME following repeated pretreatment with this agent. Thus, the stimulation of HCO-3 secretion by i.v. L-NAME may be causally related with increased BP in response to this agent.

摘要

使用麻醉大鼠的离体腔室胃,研究了重复给予一氧化氮合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME)对胃HCO₃⁻分泌的影响。静脉注射L-NAME(5mg/kg)可增加胃HCO₃⁻分泌,同时动脉血压(BP)升高。当大鼠用L-NAME(20mg/kg,口服,每日两次)预处理1天或3天后,L-NAME的HCO₃⁻刺激作用减弱,并且发现分泌刺激程度与预处理时间呈负相关。重复预处理后,对L-NAME的血压升高反应也显著减弱;基础血压在重复预处理期间呈逐步升高,在预处理3天后,静脉注射L-NAME时基础血压完全没有变化。当在L-NAME重复预处理期间,将静脉注射L-NAME诱导的HCO₃⁻输出变化量与血压变化量(相对于基础值)作图时,发现这两个因素之间存在显著关系。当动物用L-精氨酸(500mg/kg,腹腔注射,每日两次)与L-NAME一起预处理时,对L-NAME的HCO₃⁻分泌反应的降低得以恢复。然而,无论大鼠是否用L-NAME预处理,前列腺素E₂(300μg/kg,静脉注射)都会引起与L-NAME相似的胃HCO₃⁻分泌反应。相反,L-NAME对酸(0.2nmol/L HCl)诱导的胃充血反应的减弱不受L-NAME重复预处理的影响。我们得出结论,L-NAME重复口服预处理会降低静脉注射L-NAME的HCO₃⁻刺激作用,并且这种现象可能是由于在用该药物重复预处理后,对静脉注射L-NAME的血压没有进一步升高来解释。因此,静脉注射L-NAME对HCO₃⁻分泌的刺激可能与该药物引起的血压升高存在因果关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验